Document:

QuickLinks
 -- Click here to rapidly navigate through this document

Exhibit 10.29  

[***]—Certain information in this exhibit have been omitted and filed separately with the Securities and Exchange Commission. Confidential
treatment has been requested with respect to the omitted portions.

 
 

DISTRIBUTION AGREEMENT    
    

        THIS AGREEMENT entered into as of this 16th day of February, 2001 ("Effective Date"), by and between ARKRAY Inc., a Japanese corporation, having its
principal office at 57 Nishi Aketa-cho, Higashikujo, Minami-ku, Kyoto 601-8045, Japan (hereinafter referred to as "ARK"), and Heska Corporation, Delaware
corporation having its principal office at 1613 Prospect Parkway, Fort Collins, Colorado 80525, U.S.A. (hereinafter referred to as "Heska"). 

WITNESSETH

        WHEREAS,
ARK is a manufacturer and distributor of clinical diagnostic instruments and Heska is a manufacturer and/or distributor of hematology instruments, reagents and other products
targeted to veterinary markets. 

        WHEREAS,
ARK desires to appoint Heska as a distributor and Heska wishes to obtain such distribution rights to market and sell Automated Clinical Chemistry Analyzer Model
SP-4430 (hereinafter referred to as "Product") as defined herein, effective from the date of the execution of this Agreement. 

        NOW,
THEREFORE, in consideration of the foregoing premises and of the mutual covenants herein contained, the parties hereby agree as follows: 

ARTICLE I  

        ARK appoints Heska as a distributor to promote, market, service and sell Product effective from the date of execution of this Agreement, and Heska agrees to
accept such appointment subject to and in accordance with the following terms and conditions. 

1.1   Product  

        Product means product to be comprised of Automated Clinical Chemistry Analyzer Model SP-4430 ("Analyzer") and those related spare parts, consumables
and reagents manufactured by ARK to be used to analyze blood in patients as listed in Appendix A and as amended from time to time by mutual written agreement of the parties. 

1.2   Branding  

        ARK and Heska agree that the brand name and logotype of Product shall be a combination of "ARKRAY" and "HESKA" in a format to be mutually agreed upon by the
parties. 

1.3   Distribution Right  

        Heska shall have an exclusive right to promote, market, sell and distribute Product, with the right to appoint sub-distributors, in North America
("Territory") and only in the veterinary market ("Field"). The exclusivity referred to in this Agreement applies between Heska and ARK or the ARK-appointed distributors. 

        Heska
agrees that, during the term of this Agreement, (a) Heska shall not develop or make commercially available or acquire a product(s) with features identical to Product, and
(b) Heska shall not handle or otherwise provide any "off-brand" and/or "generic" form of spare part, consumables and reagents to be used with Product unless such consumables and
reagents are not available from Arkray; provided, however, this section will not apply to common laboratory transfer pipettes, common QC serum materials and primary blood collection tubes that fit
commercially available external centrifuges.

 

1.4   Sales Responsibility  

        Heska assumes all sales responsibilities for Product to be sold in the Territory and Field under this Agreement. "Sales Responsibilities" as used herein includes
all sales force training, maintenance and support activities, as well as pricing, advertising, promotion, and demonstration. ARK will provide Heska with specifications, test procedures and manuals
written in English that may be reasonably necessary for Heska to fulfill its Sales Responsibilities. 

1.5   Relationship of Parties  

        Each party shall be considered an independent contractor of the other party. Nothing in this Agreement shall be construed as establishing a joint venture or
partnership or principal/agent, or employee relationship. No party is authorized to make any statement, claim, representation or warranty or to act on behalf of any other party with respect to any of
the provisions of this Agreement, except as provided for herein or as specifically authorized in writing by other party. 

1.6   Term and Renewal  

        This Agreement shall continue in full force and effective for a period of three (3) years from the date of execution of this Agreement and shall be
automatically renewed for additional one year periods unless a party provides notice to the other party of its intent not to renew this Agreement at least one
hundred eighty (180) days prior to the current expiration date of this Agreement, unless this Agreement is terminated earlier as set forth in Section 1.7. 

1.7   Termination  

        Either party may cancel this Agreement by a written notice at any time in the event that the other party shall have been in material breach of any of the
provisions of this Agreement and such breach shall have been continued for sixty (60) days after such a written notice thereof was provided to the breaching party by the
non-breaching party. Either of the parties may terminate this Agreement at any time without giving any notice to the other party if that party is declared insolvent or bankrupt by a court
of competent jurisdiction. If Heska fails to meet the agreed upon minimum annual purchases for two (2) consecutive years, then Heska shall lose all rights to distribute Analyzer. However, ARK
shall continue to supply Heska with Consumables as provided in Section 2.3. 

        Upon
any such termination of this Agreement, the terminating party may (but has no obligation to) cancel any and all unshipped sales orders concluded hereunder. Unless otherwise provided
herein, each party waives any claims for compensation or damages in connection with such cancellation of undelivered Products from the other party. 

        The
provisions of Sections 2.3 (Spare Parts, Consumables and Reagents), 2.4 (Patents), 4.2 (Confidentiality), 4.3 (Indemnification), 4.6 (Publicity), and 4.10 (Law of Contract
Jurisdiction) shall survive termination of this Agreement. 

ARTICLE II  

2.1   Warranty and Quality  

        ARK warrants that Product to be delivered hereunder shall be free and clear of any and all liens, encumbrances or defects in title and shall be conveyed to Heska
with lawful and marketable title. ARK warrants that Product shall satisfy the performance specifications set forth in Appendix B. ARK will not make any changes to Product without first
notifying Heska in writing at least ninety (90) days in advance of such changes and providing Heska with evidence that such changes do not alter the performance specifications of Product and
obtaining Heska's consent in writing. ARK shall input

 
normal reference ranges for animals supplied by Heska in writing into the Analyzers without modification by ARK. 

        In
the event that Heska determines that any shipment of Product to be delivered to it hereunder fail/s to conform to the performance specifications set forth in Appendix B, Heska
shall promptly notify ARK and reasonably specify the manner in which Product fail/s to conform. ARK shall have the rights to make its own inspection and evaluation of the allegedly
non-conforming Product and shall notify Heska, within twenty one (21) days after receipt of such information, including samples of the allegedly non-conforming Product
from Heska, whether it has confirmed and accepted Heska's claim that Product are/is non-conforming. 

        If
ARK determines and confirms that Product are/is non-conforming, ARK shall replace, at no cost to Heska, the non-conforming Product at the earliest date after
confirmation of Product non- conformance. ARK shall also bear the freight charges, insurance, duties and tariffs for return of all non-conforming Product to ARK from Heska. 

        If,
after evaluating the allegedly non-conforming Product, ARK believes that Product in question are/is conforming, ARK shall supply Heska with its written findings and
request Heska to submit additional samples of Product to an independent third party, acceptable to both parties, for testing in accordance with and against the performance specifications set forth in
Appendix B. The decision of such third party shall be final with respect to the alleged non-conforming Product and binding on both parties to this Agreement. 

        If
the decision of the third party is that Product are/is non-conforming, ARK shall pay the return freight, insurance, duties and tariffs with respect to Product shipped to
Heska as well as all costs and expenses relating to the testing of Product by the independent third party. In addition, ARK shall supply Heska with a Certificate of Destruction certifying that Product
have/has been destroyed in an environmentally safe manner. 

        If
the decision of the third party is that Product conform/s to the applicable specifications, Heska shall accept Product and shall be responsible for the return freight, insurance,
duties, tariffs and all costs and expenses relating to the testing of Product by the independent third party. 

        Each
Product is warranted by ARK to be free from defects in materials and workmanship for a period of sixteen (16) months from the date of shipment from ARK to Heska. During the
warranty period, ARK will provide Heska with all necessary warranty replacement parts at no charge. ARK's warranty obligation under this Article is limited to the repair or replacement of Product. 

2.2   Trademark  

        ARK grants to Heska a limited license to use on a non-exclusive basis ARK's trademarks and brand names as set forth in Appendix C for the
purposes specified in this Agreement. Except as specified in this Section and Section 1.2, no party to this Agreement will derive any legal rights to the other party's trademarks. No party
shall adopt, use or register in any country, without the written consent of the other party, a trademark for any similar, related or competitive product which is likely to be confused with a trademark
of the other party. 

2.3   Spare Parts, Consumables and Reagents  

        ARK agrees that spare parts, consumables and reagents used with Analyzer (collectively called "Consumables") will continue to be furnished to Heska at the prices
fixed on the basis of the price negotiation every year for a period of five (5) years following the last shipment of Analyzer from ARK to Heska as long as Heska continues to have exclusive
distribution rights to sell Analyzer. Should Heska lose ARK's exclusive distribution rights to sell Analyzer, ARK agrees to allow Heska to be a supplier of Consumables to Heska's customers for a
period of twelve (12) months from the loss of

 
exclusive distribution rights to sell Analyzer. Thereafter, ARK agrees to supply Consumables to Heska's customers during the time ARK sells Consumables in North America directly or through a
distributor. 

2.4   Patents  

        ARK warrants and represents to Heska, and without admitting any infringement, to the best of its current actual knowledge neither Product of this Agreement nor
its manufacture, use, importation or sale infringe upon any issued patent or proprietary rights held by a third party. 

        ARK
shall defend, indemnify and hold Heska and its subsidiary or affiliated companies, and customers thereof, harmless from any damages, including without limitation reasonable
attorneys' fees, with respect to any and all claims that the manufacture, use, rental or sale of any of Product of this Agreement infringes upon any patent or proprietary rights of a third party. 

ARTICLE III  

3.1   Orders and Forecasts  

        The forecast provided for below will include a firm purchase commitment covering the first five (5) months of the forecast. Therefore, Heska will issue
periodic purchase orders within the terms specified below. Such purchase orders shall not bind ARK unless or until accepted by ARK. ARK shall notify Heska of its decision on acceptance within ten
(10) days after receipt of a purchase order. 

        Heska
shall provide ARK, on a quarterly basis by the end of each Calendar quarter, a non-binding rolling one (1) year forecast of its anticipated purchases of Product.
ARK shall keep Heska notified immediately of any events that may significantly impact ARK's ability to deliver, such as interruptions by suppliers, labor troubles, discovered defects, and the like.
ARK agrees to ship to Heska (i) Consumab1es within ninety (90) days of ARK's acceptance of a purchase order for Consumab1es, and (ii) Analyzers within one hundred twenty
(120) days of ARK's acceptance of a purchase order for Analyzers. 

3.2   Minimum Purchase  

        ARK and Heska shall separately discuss and agree on a minimum annual purchase of Product to be made by Heska from ARK for every calendar year three
(3) months prior to the beginning of every calendar year during the effective period of this Agreement. 

3.3   Pricing  

        ARK will sell Product to Heska in accordance with the prices agreed upon, which shall be denominated in Japanese yen. Upon thirty (30) day prior written
notice from one party to the other, the parties agree to discuss in good faith any adjustment to the prices of Product in an attempt to reach a mutually satisfactory agreement. If a mutually
satisfactory agreement cannot be reached, the prices of Product then in effect shall remain applicable. 

3.4   Shipping of Products, Reagents, Spare Parts and etc.  

        ARK will immediately confirm the receipt of each purchase order from Heska in order that Heska has assurance that each purchase order is duly received by ARK. ARK
shall try its best efforts to ship all of Product ordered by Heska as specified by Heska. In the event of its inability to make a complete shipment as specified by Heska, ARK shall notify Heska
immediately of the possible shipping date. Both parties shall discuss and amicably agree to adjust the shipping date if ARK's shipping date causes Heska any inconvenience. Should ARK upon acceptance
of a purchase order fail to ship Product from Japan within ten (10) business days of specified shipping dates twice within a twelve (12) month period, ARK agrees to renegotiate the
annual minimum.

 

3.5   Payment Terms  

        At Heska's sole option, Heska will provide a letter of credit or prepay in Japanese yen one week in advance of the shipment of Products under a purchase order;
provided Heska receives a timely firm shipment date in writing from ARK. Ark agrees to renegotiate the payment terms within twelve (12) months of the Effective Date. 

3.6   Packing  

        Product shall be labeled, packaged and shipped to Heska in accordance with the ARK's quality standard to satisfy the requirements for Product Specifications set
forth in Appendix B. Labels for Products shall be mutually agreed upon by the Parties. 

3.7   Freight Insurance  

        ARK will ship Heska Product ordered by Heska under the terms of FCA Osaka and/or Kobe, Japan as defined in Incoterms 2000. Heska shall be responsible for payment
of all air and/or sea freight, insurance, duties and tariffs for shipments of Product to Heska, except as both parties agree. 

ARTICLE IV  

4.1   Report  

        Heska shall make periodic reports on a quarterly basis to ARK on the sales activities and the sales promotion plans of Product, and the market conditions
including information on the competitive products. 

4.2   Confidentiality  

	(a)
	"Confidential
Information" means any technical, manufacturing, business and marketing information including, without limitation, patent applications, patent disclosure, data,
inventions, concept, idea, structures, formulas, techniques, processes, apparatus, know-how disclosed orally or in tangible form such as documents, memoranda, reports, correspondence,
machine readable tapes or disks, drawings, notes or other media. All confidential information disclosed in this Agreement which is writing or other tangible form shall be clearly marked as
"Confidential" or if communicated orally or obtained through observations, shall be confirmed in writing within thirty (30) business days.

	(b)
	The
party receiving information ("Receiving party") agrees that the party disclosing ("Disclosing party") is the owner of the confidential information and that the Receiving party
will not use any confidential information for any purpose except for the execution of this Agreement. Each Receiving party agrees not to disclose any confidential information to any third party or to
employees of the Receiving party, except to those employees who are required to have the information in order to be engaged in the execution of this Agreement. Receiving party's obligations with
regard to the confidentiality and nonuse of such information shall not extend to any information that:

	(1)
	was
in the public domain at the time it was disclosed or becomes part of public domain after disclosure, including, without limitation, disclosure in a U.S. or foreign patent or
disclosure in a printed publication which is generally available to the public, or through the unrestricted sale of Product embodying the same to the extent that such confidential information is
ascertainable from such Product; or 

 

	(2)
	was
known to the Receiving party at the time of its disclosure or becomes known to the receiving party without breach of this Agreement, provided that the Receiving party shall have
the burden of proving such knowledge: or

	(3)
	is
independently developed by the persons of the Receiving party who have not been exposed to the confidential information as evidenced by written records; or

	(4)
	is
disclosed by a Disclosing party to a third party without restrictions on such third party's rights to disclose or use the same; or

	(5)
	is
disclosed by the Disclosing party pursuant to judicial order, a requirement of a governmental agency or by operation of law, provided that the Receiving party shall (i) give
the Disclosing party prompt notice of any such possible disclosure of confidential information and (ii) permit the Disclosing party, at its expense, to take all reasonable actions to prevent or
limit the scope of such disclosure and/or to obtain protective orders to protect the confidentiality of such confidential information; or

	(6)
	is
approved for release upon the Disclosing party's prior written consent; or

	(7)
	is
disclosed by the Disclosing party to the Receiving party after written notification is delivered by the Receiving party to the Disclosing party that it will not accept any further
confidential information in confidence.

	(c)
	Each
Receiving party agrees that it shall take all reasonable measures to protect the secrecy of and avoid unauthorized use of the confidential information and that any disclosure of
the confidential information within the Receiving party will only be such as is reasonably necessary to its evaluation and will only be to employees of the Receiving party who are bound by written
agreements with the Receiving party to maintain the confidential information in confidence. Each Receiving party shall immediately notify the Disclosing party in the event of any unauthorized use or
disclosure of the confidential information.

	(d)
	The
obligations imposed on the parties under this Article shall survive for five (5) years following the termination of this Agreement. 

4.3   Indemnification  

        ARK agrees that it will defend, indemnify and hold harmless Heska, its directors, officers, employees, agents and affiliates from and against all costs, damages,
loss, expense (including reasonable attorney's fees), claims by or judgments in favor of third parties for bodily injury, property damage, or any other damage or injury caused or alleged to have been
caused by the manufacture, sale or use of the Product, except to the extent that such damage or injury results substantially from the gross negligence or wrongful acts of Heska. Furthermore, each
party agrees that it shall defend, indemnify and hold the other party, its directors, officers, employees, agents and affiliates harmless from all costs, damages, loss, expense (including reasonable
attorney's fees), or any other damage caused by, arising out of, or resulting from (i) such party's failure of performance of the terms of this Agreement, or (ii) such party's failure to
comply with any and all laws (statutory and common) and regulations applicable to such performance. Heska shall defend, indemnify and hold ARK, its directors, officers, employees, agents and
affiliates harmless from all costs, damages, loss, expense (including reasonable attorney's fees), or any other damage caused by, arising out of, or resulting from the reference ranges supplied by
Heska under Section 2.1. 

        Each
party agrees to give the other prompt notice in writing of the institution of any suit, or any claims made by a third party, including any claims asserted or made by any
governmental authority having jurisdiction over the parties and Product of this Agreement. ARK and Heska agree to cooperate with each other in the defense of such suits or claims and to provide all
necessary information to

 
enable the defending party to carry on the defense of such suit or any appeal from a judgment or decree rendered therein. 

4.4   Force Majeure  

        Except with respect to the allocation obligation of ARK provided for in Paragraph 4.3, no party shall be liable to the other in any manner for failure or
delay to fulfill all or part of this Agreement, directly or indirectly, owing to acts of God, governmental orders or restriction, war, threat of war, warlike conditions, hostilities, sanctions,
mobilization, blockade, embargo, detention, revolution, riot, looting, strike, lockout or other labor troubles, fire, typhoon, earthquake, lightning, accident of any other causes or circumstances
beyond its control. 

4.5   Notices  

        Every notice, consent, instruction, order or decision given under this Agreement shall hereunder be given or made in writing in English, and if required to be
given promptly shall be given as expeditiously as possible, and in any event, within seven (7) business days, and shall be delivered personally or if by mail, shall be mailed registered or
certified mail, return receipt requested, as follows: 

	If to ARK:

57 Nishi Aketa-cho

Higashi-kujo, Minami-ku

Kyoto 601-8045, Japan	 	If to Heska:

1613 Prospect Parkway

Fort Collins Colorado 80525

USA
	Attention:	 	Attention:	 	Chief Executive Officer
	 	 	Copy to:	 	Vice President,

Intellectual Property and

Business Development

4.6   Publicity  

        Neither
party shall announce nor disclose the existence of this Agreement or its terms and conditions, or advertise or release any publicity regarding this Agreement without the prior
written consent of the other party, which consent shall not be unreasonably withheld. This provision shall not apply to the disclosure of information required to satisfy disclosure obligations imposed
by law, court order or regulations, including, but not limited to, the reporting requirements of the United States Securities and Exchange Commission. 

4.7   Assignability  

        This Agreement and the rights and obligations hereunder shall not be assigned or transferred to any third party by either of the parties hereto without the prior
written approval of the other party; provided, however, no prior consent shall be required for the assignment or transfer of substantially all the assets of a party relating to the subject matter of
this Agreement or related to a change of control of a party. 

4.8   Waivers  

        No delay or omission in the exercise of any right or remedy of any party or any default by another shall impair any right or remedy otherwise available nor shall
it be construed as a waiver of any right or remedy. Any waiver by any party of any default must be in writing and shall not be a waiver of any other default concerning the same or any other provision.

 

4.9   Entire Agreement  

        This Agreement contains the entire understanding of the parties with respect to the subject matter hereof. All express or implied agreements and understandings,
either oral or written, heretofore made are expressly superseded by this Agreement. This Agreement may be modified only by written agreement duly executed by the parties. 

4.10 Law of Contract Jurisdiction  

        This Agreement shall be governed by and construed under the laws of the district where the contracting party is a defendant who defends against the other party,
with regard to the construction or interpretation of the Agreement. The English language employed herein shall be controlling and this Agreement shall be deemed to have been executed at Fort Collins,
Colorado, United States of America and Osaka, Japan. Any dispute, controversy or difference arising between the parties, out of or in relation to or in connection with this Agreement, or the breach
thereof, which cannot otherwise be settled between the parties within a period of ninety (90) days shall be submitted to an arbitration before a competent arbitration tribunal in Colorado,
United States of America in case Heska is a defendant, and Osaka, Japan in case ARK is a defendant, for binding resolution in accordance with the rules selected by the arbitrator(s), provided the
proceedings are conducted in the English language. 

4.11 Effect of Headings  

        Subject headings of the Sections of this Agreement are included for purposes of convenience only and shall not affect the construction or interpretation of its
provisions. 

4.12 Execution in Counterparts  

        This Agreement may be executed in two (2) counterparts, each of which shall be deemed an original but all of which together shall be deemed for all
purposes one and the same instrument. 

        IN
WITNESS WHEREOF, the parties have caused this Agreement to be executed by their authorized representatives. 

	ARKRAY Inc.	 	Heska Corporation
	

By:	
[***]
 [***]	
 	

By:	

/s/  JAMES H. FULLER      
 JAMES H. FULLER
	 	Title:	 	[***]	 	 	Title:	President and COO
	 	Date:	 	February 16, 2001	 	 	Date:	February 16, 2001
	 	Place:	 	Fort Collins, CO USA	 	 	Place:	Fort Collins, CO USA
	

By:	
[***]
 [***]	
 	

 	

 	

 
	 	Title:	 	[***]	 	 	 	 
	 	Date:	 	February 27, 2001	 	 	 	 
	 	Place:	 	Kyoto	 	 	 	 

[***]—Certain information on this page have been omitted and filed separately with the Securities and Exchange Commission. Confidential
treatment has been requested with respect to the omitted portions.

   APPENDIX A  

PRICE LIST

PL2001-01 (Second version) 

ARKRAY (Logo)  

Date:
January 23, 2001 

 

Distributor:

Heska
Corporation

1613 Prospect Parkway, Fort Collins, Colorado 80525 U.S.A.

Phone 970-493-7272 

Territory: 

        North
America 

Payment
Terms: 

        D/A
within 30 days after the Bill of Lading date 

Delivery
Terms: 

        FCA
Osaka/Kobe, Japan 

        We
reserve the right to change the prices with 30 days prior notice. 

 

Code
No.    18303 

SPOTCHEM
EZ    Model: "SP-4430" 

	Specification:	 	 	 	 
	

Sample: 	
 	

Serum, Plasma, Whole Blood (only Hb)
	

Reagent: 	
 	

SPOTCHEM II Reagent Strip
	

Measurement Items: 	
 	

Glu, UA, T-Cho, TG, BUN, T-Bil, Ca, TP, Alb, GOT, GPT, LDH, CPK, Hb, Amy, GGT, ALP, Cre, HDL-C, FRA, IP, Mg,
	 	 	**	 	Total Test Items = 22
	 	 	**	 	Max. 9 items can be measured simultaneously
	

Warm-Up: 	
 	

10 minutes
	

Display: 	
 	

20 digits × 2 lines LCD (Character)
	

Operation Panel: 	
 	

Sheet Key
	

Calibration: 	
 	

Calibration by Magnetic Card or by Calibration Kit
	

Data Storage: 	
 	

100 Measurements
	

Dimension & Weight: 	
 	

338 × 203 × 167 (WDH), Approx. 5.4kg

Including:

Thermal
Printer Paper(1), Power Cord(1), AC Adapter(1), Accessory case(1), Operating Manual(1), Warranty Card(1), Tip(10), Cleaning Wire(1), Cleaning Set(1), Nozzle Set(1), Wrench Set(1), Centrifuge
Tube(10), Tip Waste Case(2), Protective Cover(2) 

	***
	minimum
ordering unit = to be decided later 

FCA
Kobe/Osaka JP¥[***].- / unit

 

        Optional Consumable Accessories: 

	CODE NO.
 
	 	DESCRIPTION
	 	@ PRICE

FCA Japan

	10067	 	Thermal Printer Paper (For Built in Printer, 58 mm width)	 	¥ [***]
	

10204	
 	

Serum Sample Tube (100 pieces, blue cap)	
 	

¥ [***]
	

10191	
 	

Serum Sample Tube (500 pieces, blue cap)	
 	

¥ [***]
	

10202	
 	

Whole Blood Sample Tube (100 pieces, orange cap)	
 	

¥ [***]
	

10192	
 	

Whole Blood Sample Tube (500 pieces, orange cap)	
 	

¥ [***]
	

10200	
 	

Diluent for Hb measurement (20 mL, 50 pieces)	
 	

¥ [***]
	

10206	
 	

Pippete Tip for Hb Meas. (100L, 960 pieces)	
 	

¥ [***]
	

10207	
 	

Pippete Tip for Hb Meas. (1000L, 960 pieces)	
 	

¥ [***]
	

77041	
 	

Calibrator Kit (Low and High, 2 vials each, 2 vials of dilution)	
 	

¥ [***]
	

77042	
 	

Calibrator Hb Kit (Calibrator and dilution for Hb meas)	
 	

¥ [***]
	

77043	
 	

Calibration Check (4 pieces of lyophilized serum 3 mL)	
 	

¥ [***]
	

10711	
 	

Tip Set (EZ) 100 pieces	
 	

¥ [***]
	

10712	
 	

Centrifuge Cup (100 pieces)	
 	

¥ [***]
	

10743	
 	

Tip Set (EZ) (500 pieces)	
 	

¥ [***]
	

10692	
 	

AC Adaptor	
 	

¥ [***]
	

10698	
 	

Cleaning wire	
 	

¥ [***]
	

10208	
 	

Cleaner Set (Brush, 5 cotton swabs)	
 	

¥ [***]
	

10193	
 	

Pippete for Solution (For 3 mL)	
 	

¥ [***]
	

10194	
 	

Pippete for Hb Meas (For 40 mL,200L 1 each)	
 	

¥ [***]
	

10199	
 	

Sample Rack (For 30 sample tubes)	
 	

¥ [***]
	

10699	
 	

Nozzle Set (EZ) (Replacement Nozzle, O-ring)	
 	

¥ [***]
	

10700	
 	

Tool Set for Nozzle Replacement	
 	

¥ [***]
	

10701	
 	

Waste Case (2 pieces)	
 	

¥ [***]
	

10702	
 	

Protective Cover (2 pieces)	
 	

¥ [***]
	

18204	
 	

Portable Centrifuge (CF-9520)	
 	

¥ [***]
	

10703	
 	

RS-232C, Connection Cable	
 	

¥ [***]
	

10704	
 	

Carrying Case	
 	

¥ [***]

        Optional Parts: 

        "Optional
Parts List" to be supplied separately 

[***]—Certain information on this page have been omitted and filed separately with the Securities and Exchange Commission. Confidential
treatment has been requested with respect to the omitted portions.

 

SPOTCHEM
II Reagent Strips (Single Type) 

	CODE NO.
 
	 	DESCRIPTION
	 	@ PRICE

FCA JAPAN

	77240	 	Glu	 	[***]
	

77241	
 	

UA	
 	

[***]
	

77242	
 	

T-Cho	
 	

[***]
	

77243	
 	

TG	
 	

[***]
	

77244	
 	

BUN	
 	

[***]
	

77245	
 	

T-Bil	
 	

[***]
	

77246	
 	

Ca	
 	

[***]
	

77247	
 	

T-Pro	
 	

[***]
	

77248	
 	

Alb	
 	

[***]
	

77249	
 	

GOT	
 	

[***]
	

77250	
 	

GPT	
 	

[***]
	

77251	
 	

LDH	
 	

[***]
	

77252	
 	

CPK	
 	

[***]
	

77253	
 	

Hb	
 	

[***]
	

77254	
 	

Amy	
 	

[***]
	

77255	
 	

GGT	
 	

[***]
	

77256	
 	

ALP	
 	

[***]
	

77257	
 	

Cre	
 	

[***]
	

77258	
 	

HDL-C Kit	
 	

[***]
	

77259	
 	

FRA	
 	

[***]
	

77268	
 	

IP	
 	

[***]
	

77269	
 	

Mg	
 	

[***]

	*
	25
Strips/Box 

SPOTCHEM
II Reagent Strips (Multi Type) 

	CODE NO.
 
	 	DESCRIPTION
	 	@ PRICE

FCA JAPAN

	77262	 	Panel-1	 	JP¥ [***]
	

 	
 	

Vet multi panel	
 	

JP¥ [***]

	*
	25
Strips/Box 

[***]—Certain information on this page have been omitted and filed separately with the Securities and Exchange Commission. Confidential
treatment has been requested with respect to the omitted portions.

 

APPENDIX B

PRODUCT SPECIFICATIONS  

INSTRUMENT  

	SPOTCHEM EZ    MODEL: "SP-4430"
	

SAMPLE: 	
 	

Serum, Plasma, Whole Blood (only Hb)
	

REAGENT: 	
 	

SPOTCHEM II Reagent Strip
	

MEASUREMENT ITEMS: 	
 	

Glu, Ua, T -Cho, TG, BUN, T -Bil, Ca, TP, Alb, GOT, GPT, LDH, CPK, Hb, Amy, GGT, ALP, Cre, HDL-C, FRA, IP, Mg

TOTAL TESTS: 22, 9 simultaneously
	

WARM-UP: 	
 	

10 Minutes
	

DISPLAY: 	
 	

20 digits × 2 lines LCD (character)
	

OPERATION PANEL: 	
 	

Sheet key
	

CALIBRATION: 	
 	

Magnetic card or kit
	

DATA STORAGE: 	
 	

100 measurements
	

DIMENSION & WEIGHT	
 	

338 × 203 × 167 (WDH), Approx 5.4 kg
	

SOTWARE: 	
 	

Menu sub routine for species selection & normal values
	

WARRANTY: 	
 	

16 Months

REAGENTS

[***] 

	 	 	 	 	[***]	 	 	 	 	 	 
	 	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	GLU	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	BUN	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	T-BIL	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	CA	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	T-PRO	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	ALB	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	GPT	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	AMY	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	GGT	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	ALP	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	CRE	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	IP	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	GOT	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	FRA	 	 	 	 	 	 	 	 	 	[***]
	CPK	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	Mg	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	TG	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	UA	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	T-CHO	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	LDH	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	Hb	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	HDL-C(D)	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	PANEL-1	 	[***]	 	[***]	 	[***]	 	[***]	 	 
	 	 	[***]	 	 	 	 	 	 	 	 

[***]

        [***] 

[***]—Certain information on this page have been omitted and filed separately with the Securities and
Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

 

	Color specifications	 	Basic design system
	

 	
 	

1-7-1

	ARKRAY blue

  

(Example of color)	 	  

  

If D1C641 is not available

—C100 + M60

—PANTONE293	 	ARKRAY mark is expressed in the two colors, ARKRAY blue and ARKRAY orange. ARKRAY blue is the corporate color, representing fair, good faith and "truthful" stated in our corporate philosophy.
	

ARKRAY orange

 

(Example of color)	
 	

 

 

If DIC205 is not available

—M50 + Y90

—PANTONE136	
 	

ARKRAY orange indicates vitality, meaning "active" in the corporate philosophy. ARKRAY logo should be painted in black. In case the number of color is limited, follow the coloring specifications below.
	

Coloring instruction	
 	

 	
 	

 
	

 	
 	

Color type	
 	

 
	

(Example of ARKRAY logo)	
 	

 	
 	

(Example of ARKRAY logo)
	
Prototype (basically used)	
 	

 	
 	

If the prototype cannot be used due to the limitation of the number of colors, use ARKRAY blue and ARKRAY orange as shown above.
	

 	
 	

Monochrome types	
 	

 
	

(Example of ARKRAY logo)	
 	

 	
 	

(Example of ARKRAY logo)
	
Monochrome type 1	
 	

 	
 	
Monochrome type 2
	

Use black and meshed black 40% as shown above. If the black is not available to use, use ARKRAY blue (or the most similar color) instead of black.	
 	

 	
 	

If the meshed black is not clearly shown in monochrome print, use black only.
	

 	
 	
Reversed color type	
 	

 
	

(Example of ARKRAY logo)	
 	

 	
 	

If the ARKRAY colors don't look attractive due to the color of foundation the ARKRAY brand is on, use white only shown at the left.

 

APPENDIX C 

	ARKRAY brand specifications 1	 	Basic design system
	

 	
 	

1-4-1

	Prototype

  

(Example of ARKRAY logo)	 	  

ARKRAY brand consists of

ARKRAY mark and logo.
	

 	
 	

Basically the prototype should be used.
	

Sub-design

 

(Example of ARKRAY logo)	
 	

 

 

If the prototype cannot be used due to size of space, use the sub-design instead.
	

Isolation

  

—Prototype

  

(Example of ARKRAY logo)

  

—Sub-design

  

(Example of ARKRAY logo)	
 	

  

  

The isolation is the minimum sized space surrounding the ARKRAY brand to set it apart from other factors in order to make the design prominent. Do NOT allow other factors to enter the space.

QuickLinks

DISTRIBUTION AGREEMENTQuickLinks
 -- Click here to rapidly navigate through this document

Exhibit 10.30  

[***]—Certain information in this exhibit have been omitted and filed separately with the Securities and Exchange Commission. Confidential
treatment has been requested with respect to the omitted portions.

 
 

SUPPLY AND DISTRIBUTION AGREEMENT    
    

        This Agreement entered into by and between Heska Corporation, a Delaware corporation, having a principal place of business at 1613 Prospect Parkway, Fort Collins,
Colorado 80525 ("Heska,") and Boule Medical AB, a Swedish corporation, having a principal place of business at Vastberga Alle 32, P.O. Box 42056, SE-126 13 Stockholm, Sweden
("Boule"). 

        In
consideration of the covenants and obligations set forth in this Agreement, the Parties hereby agree as follows: 

1.     Definitions  

        1.1   "ABC
System" shall mean the veterinary hematology analyzer supplied to Heska under an agreement with Scil GmbH (Formerly Praemix Wirkstoff GmbH) dated June 18,
1998. 

        1.2   "Analyzer"
means the Ca 620-16 or Ca 530-16 Veterinary Hematology Analyzer manufactured by Boule. 

        1.3   "Affiliate"
means all entities at least fifty percent (50%) owned or controlled by a Party, an entity which directly or indirectly owns or controls more than fifty
percent (50%) of the voting stock of a Party, and any entity, the majority ownership of which is directly or indirectly common to the ownership of a Party. 

        1.4   "Calendar
Year" shall mean, with respect to the first Calendar Year, the period commencing on the first date of purchase of Product by Heska for commercial sales and
ending on December 31, 2004. The second year and all subsequent Calendar Years shall commence on January 1 and end on December 31 of each year thereafter. "Calendar Half Year"
shall mean each six months period ending on the last day of June and December. "Calendar Quarter" shall mean each three month period ending on the last day of March, June,
September and December. 

        1.5   "Effective
Date" shall mean the date this Agreement is executed by the last to sign Party. 

        1.6   "Field"
shall mean the veterinary market. 

        1.7   "Party
or Parties" shall mean Heska, Boule or both as the context indicates. 

        1.8   "Product"
shall mean the Analyzer and associated spare parts, consumables and reagents listed in Appendix A, and ABC System reagents. 

        1.9   "Territory"
shall mean North America. 

2.     Grant  

        2.1   Distribution Right. Boule hereby grants Heska the exclusive right to promote, market, sell and distribute Product in the
Field and within the Territory. 

        2.2   Subdistributors. Heska shall have the right to appoint subdistributors to promote, market, sell and distribute Product in
the Field and within the Territory. 

        2.3   Restrictions. Without the prior written consent of Boule, Heska undertakes not to manufacture or distribute within the
Territory any products that are similar or identical to or otherwise competing with any of the Products, except Heska shall have the right, but not the obligation, to sell its inventory of reagents
and instruments purchased from Scil, Inc. for a period of one year from the Effective Date of this Agreement.

 

        Moreover,
Heska will refrain without Boule's prior written consent, to the extent admissible under any mandatory law applicable to this Agreement, from selling, directly or indirectly,
any Products to customers outside the Territory and/or the Field or, to the best of Heska's knowledge, Products otherwise intended for use outside the Territory and/or outside the Field. 

        2.4   Should
Boule decide not to commercialize ABC System reagents in any country outside North America, Heska shall have the first right of refusal for distribution in
territories available under Boule's agreement with [***]. Boule agrees not to commercialize the ABC System reagents before Heska starts selling the product. 

        2.5   New Product Development. [***] 

3.     Supply of Product  

        3.1   Forecasts. At least ninety (90) days prior to each Calendar Quarter after the Product is available for purchase by
Heska, Heska shall provide Boule a binding forecast of anticipated purchases of Product for such Calendar Quarter, and a non-binding rolling twelve (12) month forecast of
anticipated purchases of Product. Product shall be available for purchase by Heska on or before October 1, 2003. 

        3.2   Purchase Orders. Written purchase orders shall be submitted by Heska to Boule at least ninety (90) days prior to
the requested delivery date. No purchase orders for the Product shall be binding upon Boule until accepted in writing by Boule. Boule agrees to review promptly all purchase orders placed by Heska and
to notify Heska of acceptance or rejection of such purchase orders without delay. Boule shall use its best efforts to deliver the Products on or before the date specified in the accepted purchase
orders or as soon thereafter as is reasonably possible. Boule shall however not be liable to pay any damages due to its late delivery. 

        3.3   Purchase Minimums. The minimum purchase commitment for the first Calendar Year of commercial sale shall be two hundred
(200) Analyzers. For each subsequent Calendar Year, the Parties will mutually agree upon annual minimums for the purchase of Analyzers by Heska at least three (3) months prior to the
beginning of each subsequent Calendar Year. Should the Parties fail to reach such an agreement, the minimum commitment for the subsequent Calendar Year shall remain the same as the minimum purchase
commitment for the immediately preceding Calendar Year. Should Boule fail to deliver Product that conforms to the Specifications set forth in Appendix B within 90 days of receiving a
purchase order more than once per Calendar Year, Boule agrees to readjust the minimum purchasing commitment as mutually agreeable to the Parties. 

        3.4   Delivery and Acceptance. Product shall be delivered F.O.B. Stockholm, Sweden (INCOTERMS 2000), in accordance with Heska's
instructions and to the location specified by Heska. 

        Each
shipment of Product to Heska will be accompanied by a quality control certificate. The certificate shall be issued in compliance with the specification of Appendix B, which
specification shall be used for acceptance or rejection of Product by Heska. Heska will promptly inspect each shipment and will inform Boule if a shipment is non-conforming to such
specifications. Unless Heska advises Boule that a shipment is non-conforming within forty-five (45) days of its receipt, the shipment will be deemed accepted by Heska.
The provisions set out in Section 6.1 (c) below shall apply in respect of any non-conforming Product. Boule shall pay a rejection rate of one percent (1%) of the purchase
price for any such non-conforming Product. 

        3.5   Labels. Labels for Product, including storage and handling instructions, shall be mutually agreed upon by the Parties.
Any additional labeling costs incurred as a result of such agreement shall be borne by Heska, unless required by Boule.

 

        3.6   Consumables. Unless Boule terminates this contract pursuant to Section 8.2 below, Boule agrees that spare parts,
consumables and reagents identified in Appendix A (collectively referred to as "Consumables") will continue to be supplied, on a non-exclusive basis, to Heska by Boule under the
terms of this agreement for a period of five (5) years following the termination of this contract; provided, however that Boule shall provide Heska Consumables at terms at least as favorable as
Boule offers to any other customer(s). Should Boule terminate this contract pursuant to Section 8.2 (a), (b), or (e), Boule agrees to supply Consumables to Heska and to allow Heska to be a
supplier of Consumables to Heska's customers for a period of twelve (12) months from the termination. Thereafter, Boule agrees to supply Consumables to Heska's customers in a country within the
Territory during the time Boule sells Consumables in that country directly or through a distributor. 

        3.7   New Products. Boule shall offer Heska all new Boule products with potential veterinary application ("New Products").
Heska shall have a first right of refusal for period of sixty (60) days from receipt of a written offer by Boule to express an interest in any New Product. If Heska expresses an interest in a
New Product, the Parties agree to engage in good faith negotiations to add the New Product to this Agreement upon mutually acceptable terms signed by the Parties. 

4.     Prices and Payment  

        4.1   Prices. The purchase price of Product to be paid by Heska to Boule shall be as set forth in Appendix A. All
applicable sales taxes, shipping fees and insurance with respect to the transfer of Product from Boule's facility to Heska's designated location shall be paid by Heska. All prices and fees shall be
defined in Euros. 

        Beginning
September 30, 2004 and every September 30 as long as this agreement shall be in effect, Heska and Boule shall set the "Base Price" for both the CA
620-16 Vet, 110/60 and the CA-16 Vet with MPA, 110/60, which shall be subject to cumulative annual price adjustments as detailed later in this section, based on an "Exchange
Rate", as defined later in this section, as follows: 

	 
	 	Base Price (EUR)

	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]

        Where
Exchange Rate is the average USD/EUR exchange rate for the period beginning on July 1 and ending on September 30 of the current year as reported by the Financial
Times of London. 

        Boule
may, after January 1, 2004, and subject to the restrictions set forth herein, adjust the Analyzer or Consumables purchase prices in Appendix A to pass through actual
changes in the raw material and labor costs associated with the manufacture of the said Products, although the adjustment for labor costs shall by itself not cause price increases of more than 3%
annually. There shall not be more than one (1) upward adjustment of each of the Product prices during any Calendar Year for any and all reasons. Boule shall provide Heska prior written notice
by September 30 of any proposed increase in the purchase price for the next Calendar Year. Boule agrees to keep true and accurate books of accounts relating to the manufacture of the said
Products and agrees further to make said books freely available to Heska during ordinary business hours to the extent necessary to verify any such price adjustments. If the proposed increase in
the purchase price of Analyzer, Consumables or reagents is unacceptable to Heska, the Parties shall mutually agree upon a reduced minimum purchase commitment for the subsequent Calendar Year. If the
Parties are unable to reach a mutually agreeable minimum purchase commitment, either Party shall have the right to terminate the Agreement and Boule shall continue to supply Consumables as provided in
Section 3.6. 

        4.2   Payment. For payment terms, see Appendix A.

 

        4.3   Resale Product Prices. Heska shall have the unrestricted right to determine the prices at which it resells the Products
purchased under this Agreement. Boule shall not have the authority to require or suggest that Heska charge a particular resale price for the Products purchased from Boule. 

5.     Marketing  

        5.1   Marketing Support. Notwithstanding Section 4.1, Boule agrees to provide fifteen (15) Analyzers at a
discount of thirty percent (30%) for use as demonstration units for Heska's marketing and sales activities. This discount is not possible to combine with other discounts. Boule agrees to provide
reasonable technical assistance and training, as requested by Heska, to: (a) enable Heska to market, sell and distribute Product; (b) enable Heska to install, operate and use the
Product, and (c) educate Heska about improvements to Product. Such technical assistance shall be provided at Boule's expense to the extent not exceeding five working days for one person.
Any additional technical assistance shall be subject to the payment of a mutually acceptable consulting rate. Boule will provide an electronic copy of the operator's manual and all updates to Heska. 

        5.2   Trademarks. Boule grants Heska a limited, non-exclusive license to use Boule trademarks and brand names as
set forth in Appendix C for the purposes of marketing and selling Product. Except as specified in this Section, Heska shall not derive any legal rights to Boule's trademarks or brand names.
Heska shall use Boule's trademark and brand names solely in accordance with such instructions as Boule may give from time to time. 

        5.3   Product Improvements. Boule shall notify Heska in writing of any improvements to Product developed by Boule useful for
veterinary applications. Subject always to mutual agreement and available resources in each separate case, Boule further agrees to support on-going Product development activities with
Heska. 

        5.4   Complaints/Recalls. Boule will use reasonable efforts to assist Heska in investigating and correcting any problems Heska
or its customers may experience with the Product. Such efforts will include visiting the Territory by Boule's representatives only where deemed necessary by Boule. Heska will use reasonable efforts to
implement any corrective action deemed necessary by Boule. Heska further agrees to reasonably cooperate with Boule in any mandatory or voluntary Product recall by assisting in the notification of all
affected customers, using materials and documentation that are mutually acceptable to the Parties. 

        5.5   Marketing Efforts. Heska shall in performing this Agreement devote reasonable commercial efforts to market, distribute
and sell the Product in the Territory and in the Field. 

        5.6   Reports. Heska shall within one month from the expiry of each Calendar Half Year submit to Boule a report on the sales of
such Calendar Half Year together with such general market information as may be deemed to be of interest and relevant to Boule or as Boule may from time to time request. The report shall also specify
major sales and marketing activities. 

        5.7   Approvals, Etc. Heska shall at its own expense obtain all approvals and other authorisations and file all notices which
are required to be obtained or filed for the sale and use of the Product in the Territory. Moreover, Heska shall keep Boule currently informed of all laws, rules and regulations applicable in the
Territory directly affecting the sale and use of the Product. The Parties acknowledge the Products are currently not regulated by any government agency within the Territory. Should the Products become
regulated during the term of this Agreement, the Parties shall negotiate in good faith terms and conditions for allocating the responsibility and costs for obtaining regulatory approval.

 

6.     Warranty  

        6.1   Warranty. Boule warrants that: 

        (a)   the
Product shall be free and clear of any and all liens, encumbrances, or defects in title and shall be conveyed to Heska with lawful and marketable title (save as said
in paragraph (b) below); 

        (b)   to
the best of its knowledge, neither the Products nor their manufacture, use, importation or sale infringe upon the proprietary rights held by a third party. In the
event of an allegation of infringement of any third party intellectual property rights is made, or in Boule's and Heska's opinions is likely to be made, in respect of the Product Boule may at its own
expense (i) obtain for Heska and its customers the right to continue to import, sell and use the Product, (ii) modify the Product so as to avoid infringement in a way reasonably
acceptable to Heska or (iii) if conditions (i) and (ii) cannot be complied with on terms which in Boule's opinion are reasonable, terminate this Agreement without any liability
towards Heska, unless such liability could be covered under the agreement between Boule and [***]. If the Agreement is terminated Boule undertakes during a period of twelve
months following such termination before appointing any new distributor in the Territory to offer Heska the right of first refusal to such distribution rights; and 

        (c)   the
Product conforms to the specifications as set forth in Appendix B and are free from defects in material and workmanship during a fifteen(15) month warranty
period under normal use from the date of delivery as per Section 3.4 ("Warranty Period") for the Analyzers and 12 month expiration dating for reagents. The warranty covers, at Boule's
exclusive choice, its replacement or repair of the non-conforming or defective Product. If requested by Boule, Heska shall return to Boule at Heska's cost and expense the
non-conforming or defective Product. In order to avail itself of its rights hereunder Heska shall have given Boule notice in writing of the non-conforming or defective Product
within the Warranty Period. Save as stipulated in this paragraph (c) Boule shall not be liable in respect of any non-conforming or defective Product. 

        (d)   Boule
holds the exclusive rights to ABC System reagents in the Territory from [***] and that the marketing, sale and distribution of such
reagents do not and will not infringe the intellectual property rights of a third party. 

        6.2   Repairs. During the Warranty Period, Heska shall at the request of Boule and may at Heska's choice elect to provide
warranty service at Heska's designated facilities for the repair of defective Products. Boule agrees to provide, at Boule's sole expense, one (1) week of service training to Heska's personnel
at Heska's facility. Boule further agrees to provide additional training, as requested by Heska, at a mutually acceptable consulting rate. Boule will provide an initial pool of five
(5) Analyzers at no charge to Heska to serve as loaners to Heska's customers during warranty service repairs. The Parties agree that additional Analyzers may be added to the pool of loaner
units depending on mean time between failure (MTBF) rates and service turn around times required to perform warranty service repairs. 

        6.3   Audits. Heska shall have the right to the extent necessary for the purpose of examining the Product quality standards
maintained by Boule to audit Boule's original records and to inspect Boule's facilities upon reasonable written notice to Boule. 

        6.4   Product Changes. Boule will not make any changes to Product affecting its performance without providing at least
forty-five (45) days prior written notice to Heska. 

        6.5   Indemnification. Boule will defend, indemnify, and hold Heska and its directors, officers, employees, agents and
Affiliates, harmless from any and all claims, liabilities, direct damages and reasonable out-of-pocket expenses, including reasonable attorney's fees and costs, arising from or
related to any and all claims arising as a result of the marketing, sale, or use of any defective Product

 
by Heska or its customers or arising from any breach of warranty under Section 6.1 hereof, except to the extent that such losses, claims, liabilities, damages or expenses result from the
negligence or wrongful acts of Heska or any of its customers or from a defect for which Boule is not responsible. Heska will defend, indemnify, and hold Boule and its directors, officers, employees,
agents and Affiliates, harmless from any and all claims, liabilities, direct damages and reasonable out-of-pocket expenses, including reasonable attorney's fees and costs,
arising from or related to any and all claims arising as a result of the marketing, sale, or use of any defective Product by Heska or its customers to the extent that such losses, claims, liabilities,
damages or expenses result from the negligence or wrongful acts of Heska or any of its customers or from a defect for which Boule is not responsible. Both Parties shall maintain during the term of
this Agreement and for a period of three years thereafter adequate product liability insurance. 

        6.6.  Disclaimer. EXCEPT AS OTHERWISE EXPRESSLY PROVIDED HEREIN, BOULE DISCLAIMS ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING
WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. 

7.     Confidential Information  

        7.1   Obligation to Protect. Each of the Parties shall take such steps as are reasonably required (including without limitation
such steps as such Party takes to protect its own proprietary information) to protect confidential and/or proprietary information ("Confidential Information") supplied or revealed to it by the other
Party pursuant to this Agreement, and shall not, directly or indirectly, disclose to any third party or use such information except pursuant to this Agreement. Any Confidential Information and/or
proprietary information shall be in writing and clearly designated Confidential, or if initially disclosed orally, confirmed in writing within thirty (30) days of disclosure. 

        7.2   Scope of Obligation. Nothing in this Article 7 shall be construed to impose a confidentiality obligation on a
Party in connection with any information to the extent such information (a) is at the time of disclosure already known to the receiving party (as clearly established by such Party's prior
written records); (b) is at the time of disclosure or subsequently becomes part of the public domain through no fault, act, or omission of the receiving Party; (c) is subsequently
disclosed to the receiving Party by a third party whose receipt and disclosure of such Confidential Information does not, according to the receiving Party's knowledge, constitute a violation of any
confidentiality obligation; (d) is independently developed by the receiving Party by employees having no access to or knowledge of Confidential Information received; or (e) is required
by a court or government agency; provided that the disclosing party shall use reasonable efforts to provide the other party notice in writing of any proposed disclosure under this
subsection and an opportunity to object to the disclosure or seek confidential treatment thereof. 

        7.3   Return of Information. The receiving Party shall return all Confidential Information provided by the disclosing Party,
and any documents or materials incorporating such Confidential Information, upon the expiration or termination of this Agreement; provided, however, one copy of all such Confidential Information may
be retained in the legal files of the receiving Party to assure compliance with the confidentiality and non-use provisions of this Article 7. 

8.     Term and Termination  

        8.1   Term. Unless terminated earlier as provided herein, this Agreement shall be effective from the Effective Date and shall
remain in effect until December 31, 2008. Thereafter, the term of this Agreement shall be automatically renewed for additional one (1) year terms; provided, however that either Party may
provide written notification to the other Party of its intent not to renew at least 180 days prior to the next expiration date.

 

        8.2   Termination. This Agreement may be terminated: 

        (a)   at
any time upon the mutual written consent of the Parties; 

        (b)   by
Boule if Heska fails to meet the minimum purchasing commitments under Section 3.3 for two (2) contractual years; 

        (c)   for
a material breach of this Agreement upon sixty (60) days prior written notice to the breaching party if during such sixty (60) day period, the default
is not cured to the reasonable satisfaction of the non-defaulting Party; 

        (d)   by
giving the other Party sixty (60) days written notice if such other Party has entered into or committed any act of liquidation, bankruptcy, insolvency,
receivorship, or assignment for the benefit of creditors, to the extent such act is permitted by law; or 

        (e)   by
Boule if Heska sells a competing product as defined in Section 2.3. 

        8.3   Effect of Termination; Repurchase of Products. Except as otherwise specified in this Agreement, upon termination of this
Agreement Boule shall be entitled to repurchase from Heska Products that Heska may have in stock when this Agreement ceases to be in effect at a price equal to the price paid by Heska to Boule for
such Products plus transportation costs, customs duties and other expenses incurred by Heska. Should Boule elect not to repurchase such Products, Heska shall have the right, but not the obligation, to
sell Products in stock. Upon termination of this Agreement, Boule shall continue to supply Consumables to Heska as provided in Section 3.6. 

        8.4   Dispute Resolution. The Parties covenant and agree in good faith to attempt for a period of sixty (60) days to
resolve any disputes which may arise in connection with this Agreement through negotiation and settlement prior to giving notice of termination or bringing any legal action against the other Party in
connection with this Agreement. During such negotiations, the Parties shall also consider the possibility of using alternative dispute resolution methods, including arbitration and mediation, if the
Parties are unable to resolve the dispute. The provisions of this section shall not apply if one Party refuses to negotiate the dispute in good faith or if more prompt legal action is required
to avoid material loss or damage. Failure to resolve a dispute by negotiated settlement shall not prejudice any subsequent legal action with respect thereto. 

9.     Miscellaneous  

        9.1   Relationship of Parties. The relationship of Boule to Heska under this Agreement is intended to be that of independent
contractor. Nothing contained in this Agreement is intended or is to be construed so as to constitute Boule and Heska as employer/employee or principal/agent, or the employees or the agents of any
Party hereto as employees or agents of the other Party hereto. Neither Party hereto has any express or implied right or authority under this Agreement to assume or create any obligations on behalf of
or in the name of the other Party or to bind the other Party to any contract, agreement, or undertaking with any third party, other than the successors and permitted assigns of the respective parties
hereto. 

        9.2   Assigmnents. This Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective
successors and assigns; provided, however, that neither Party shall have the right to transfer or assign its interest in this Agreement without the prior written consent of the other Party, except
that either Party may make such transfer or assignment, to a partner, subsidiary or entity otherwise controlling, controlled by or under common control with such Party, or to an entity acquiring all
or substantially all relevant assets of a Party to which this Agreement pertains. No transfer or assignment will relieve the transferor or assignor of any liability or obligations hereunder. 

        9.3   Waiver of Performance. A failure of a Party hereto at any time to require performance by the other Party hereto of any
provision hereto required to be performed by such other Party, will in no way

 
affect the right of the first party to require such performance at any time thereafter. The waiver of any breach of any provision hereto will in no way be construed as a waiver of any succeeding
breach of such provision or a waiver of the provision itself. 

        9.4   Severability. In the event any provision of this Agreement shall be invalid, void, illegal, or unenforceable, the
remaining provisions hereof nevertheless will continue in full force and effect without being impaired or invalidated in any way. 

        9.5   Survival. The provisions of Section 5.4, Articles 6, 7 and 8, and Section 9.8 shall survive the termination
of this Agreement. 

        9.6   Notices. All notices under this Agreement shall be in writing and shall be deemed given if sent by facsimile, (except for
the legal process in each case), certified or registered mail or commercial courier (return receipt or confirmation of delivery requested), or by personal delivery to the party to receive such notices
or other communications called for by this Agreement at the following addresses for a party as shall be specified by such party by like notice: 

If
to Boule: 

Boule
Medical AB

P.O. Box 42056

SE-126 13 Stockholm, Sweden

[***]

Attention: President 

If
to Heska: 

Heska
Corporation

1613 Prospect Parkway

Fort Collins, CO 80525

[***]

Attention: Chief Executive Officer

Copy to: Executive Vice President, Intellectual Property and Business Development

[***] 

        9.7   Force majeure. Either Party shall be excused from the performance of its obligations hereunder, or such performance may
be delayed, by causes beyond its reasonable control, including without limitation, acts of God, war, riot, epidemic, fire, flood, insurrection, military authorities, labor disputes, delay or inability
to obtain supplies, labor, raw materials, energy or failure of transportation or communication and any other similar contingency, provided that if such nonperformance continues for more than
90 days, the other party may terminate the Agreement upon written notice. 

        9.8   Governing Law. The Parties agree that their rights and obligations under this Agreement will not be governed by the
United Nations Conventions on Contracts for the International Sale of Goods, the application of which is expressly excluded. Rather, this Agreement shall be governed by and construed under the laws of
the district where the contracting party is a defendant who defends against the other Party, with regard to the construction or interpretation of the Agreement. The English language employed herein
shall be controlling and this Agreement shall be deemed to have been executed at Fort Collins, Colorado, United States of America and Stockholm, Sweden. Any dispute, controversy or difference arising
between the Parties, out of or in relation to or in connection with this Agreement, or the breach thereof, which cannot otherwise be settled between the Parties within a period of ninety
(90) days shall be submitted to an arbitration before a competent arbitration tribunal in Colorado, United States of America in case Heska is a defendant, and Stockholm, Sweden, in case Boule
is a defendant, for binding resolution in accordance with the rules selected by the arbitrator(s), provided the proceedings are conducted in the English language.

 

        9.9   General Terms of Sale. Boule's General Terms of Sale as amended from time to time shall apply in respect of all supplies
hereunder save as varied by express provisions herein. The currently applicable General Terms of Sale have been attached hereto as Appendix A. 

        9.10 Entire Agreement. This Agreement and the Appendices hereto constitute the entire agreement and understanding of the
Parties with regard to the subject matter hereof and supercede all prior agreements and understanding, written or oral, between the Parties. This Agreement may only be amended by a written agreement
signed by the Parties. 

        The
Parties have caused this Agreement to be signed by their duly authorized representatives. 

	

BOULE MEDICAL AB	
 	

HESKA CORPORATION
	

By:	
 	

/s/  ERNST WESTMAN      
	
 	

By:	
 	

/s/  JASON NAPOLITANO      

	Name:	 	ERNST WESTMAN
	 	Name:	 	JASON NAPOLITANO

	Title:	 	President
	 	Title:	 	Chief Financial Officer

	Date:	 	June 17, 2003
	 	Date:	 	June 17, 2003

   [***]—Certain information on this page have been omitted and filed separately with the Securities and Exchange Commission.
Confidential treatment has been requested with respect to the omitted portions.

Appendix A1  

        This Appendix forms an integrated part of the Distributorship Agreement between BOULE and HESKA. 

        Payment
Terms 

        All
prices are based on EX Works delivery terms, not insured, 50% in Euro and 50% in USD based on a fixed exchange rate of 1.18 USD/EUR. For example, if Heska buys two CA
620-16, 110-60, price Net Euro [***], Heska would pay EUR [***] and USD [***] for the two instruments.
Heska agrees to make orders in units divisible by two. 

        Insurance
could be organised according to a request from the receiver. 

        All
additional costs are on the behalf of Heska, such as: 

	•
	L/C
cost

	•
	Legalisation
costs

	•
	Courier

        Minimum
order/invoicing amount: Euro 100 

        Payment
terms 

	•
	Boule
will invoice Heska twenty percent (20%) of the purchase price of instruments immediately upon acceptance of any purchase order. Heska shall wire the 20% payment
fourteen (14) days prior to shipment. Boule will invoice the balance of the purchase price upon shipment of Product from Boule's facility and Heska shall pay such invoice within
fifty-two (52) days from the date of invoice. This term shall be valid only as long as Heska complies with said payment term without delays, as judged by Boule. For payments
received in advance Heska will be granted a 2% discount.

	•
	Interest
rate of 2% per month will be charged for all invoices past due date. Interest invoices will be made, at least, twice a year.

	•
	Credit
limit is set to Euro five hundred thousand (500.000) 

 

[***]—Certain information on this page have been omitted and filed separately with the Securities and Exchange Commission.
Confidential treatment has been requested with respect to the omitted portions.

Appendix A2  

        This Appendix forms an integrated part of the Distributorship Agreement between BOULE and HESKA. 

        Price
schedule 

	Description
 
	 	Price Net Euro

	INSTRUMENTS	 	 
	CA 620-16 Vet, 110/60	 	[***]
	CA 620-16 Vet with MPA, 110/60	 	[***]
	CA 620-20 Vet, 110/60	 	[***]
	CA 620-20 Vet with MPA, 110/60	 	[***]
	Micro Pipette Adapter MPA	 	[***]
	Micro caps for MPA Pack size 10/1000	 	[***]
	Medonic micro lancet	 	[***]
	Printer DPU 414-2	 	[***]
	Printer paper to DPU 414-2, 5 rolls	 	[***]
	Barcode reader	 	[***]
	

REAGENTS	
 	

 
	Mediton vet, 10 Litre (for Medonic)	 	[***]
	Medilyse vet, 5 Litre (for Medonic)	 	[***]
	Reagent Pack AB-Vet (for ABX)	 	[***]
	ProClean Plus	 	[***]
	Hypochlorite	 	[***]
	

CONTROLS & CALIBRATORS	
 	

 
	Boule—8 VET CON	 	 
	1x4, 5 ml normal	 	[***]
	6x4, 5 ml normal	 	[***]
	18x4, 5 ml normal	 	[***]
	Boule—8 VET CAL	 	 
	1x3, 0 ml	 	[***]

   APPENDIX B  

Product Specification  

        Product Specification CA 620 Vet 

	•	 	Measuring principle RBC, WBC, PLT	 	Impedance
	•	 	Measuring principle HGB	 	Cyanide free method 540 nm
	•	 	Discriminator	 	Floating programmable
	•	 	Sampling system	 	Shear valve
	

•	
 	

Parameters reported (16 par. model):	
 	

RBC, MCV, HCT,
	 	 	 	 	PLT, MPV
	 	 	 	 	HGB, MCH, MCHC
	 	 	 	 	WBC,
	 	 	 	 	RDW%
	 	 	 	 	LYMPH abs, MID abs, GRAN abs.
	 	 	 	 	LYMPH %, MID %, GRAN %
	

•	
 	

Size distributions printed for	
 	

RBC, PLT and WBC diff.
	

•	
 	

Aspirated blood volume (open tubes)	
 	

ca. 125 ul
	•	 	Blood volume using the Micro Pipette Adapter	 	20 ul
	

•	
 	

Prediluted mode	
 	

1:200 to 1:250 using min. 20 ul blood
	 	 	 	 	e.g. 20 ul to 5 ml diluent
	 	 	 	 	30 u1 to 6 m1 diluent
	 	 	 	 	40 u1 to 8 ml diluent
	

•	
 	

Screen	
 	

LCD
	•	 	Keyboard	 	Numerical
	•	 	Total cycle time	 	ca. 73 seconds
	•	 	Sample display and print after	 	ca. 53 seconds
	

•	
 	

Printer	
 	

external, IBM, HP format
	 	 	 	 	or DPU414
	

•	
 	

Memory	
 	

>350 samples
	

•	
 	

QC capability	
 	

SD, CV, Xm
	•	 	HGB correction on high WBC counts	 	Yes
	

•	
 	

Warning flags on parameter abnormalities	
 	

Yes
	•	 	Floating discriminator RBC/ PLT	 	Yes (position printed)
	•	 	Mathematical 3-part diff. WBC calc.	 	Yes
	

•	
 	

Automatic HGB blank on each sample	
 	

Yes
	•	 	Carry Over	 	< 1%
	•	 	Bar-code scanner input	 	Yes
	•	 	Serial output	 	Yes
	

•	
 	

Mains voltage	
 	

230 V or,
	 	 	 	 	120 V

 

	

•	
 	

Mains voltage tolerances	
 	

+15% /-20%
	•	 	Power consumption	 	max 250 VA
	•	 	Power consumption (standby)	 	max 50 VA
	

•	
 	

Built-in test /adjustment programs	
 	

Yes
	

Dimensions (mm)	
 	

H=350 W=420 D=460
	Weight	 	ca. 22 Kg

 

[***]—Certain information in this exhibit have been omitted and filed separately with the Securities and Exchange Commission. Confidential
treatment has been requested with respect to the omitted portions.

June 1,
2004 

Boule
Medical AB

P. O. Box 42056

SE-126 13 Stockholm, Sweden 

Attention:
Ernst Westman, President 

	Re:
	Supply
and Distribution Agreement ("Distribution Agreement") by and between Heska Corporation
("Heska") and Boule Medical AB ("Boule") dated June 17, 2003 

Dear
Mr. Westman: 

        This
letter confirms our agreement to interpret and supplement the Distribution Agreement as follows (capitalized terms not otherwise defined herein have the meanings ascribed to them in
the Distribution Agreement): 

        1.     Pricing and Payment. Appendix Al and Appendix A2 of the Distribution Agreement are hereby deleted in their entirety and
replaced with Appendices AI, A2, A3, A4 and A5 attached hereto. The last sentence of the first paragraph of Section 4.1 of the Distribution Agreement is hereby amended to read as follows: "All
prices and fees shall be defined in Euros and/or US Dollars, as provided in Appendices A2, A3, A4 and A5." 

        2.     Appendix C. Appendix C to the Distribution Agreement is attached hereto. 

        3.     Returns. Notwithstanding any provision of Section 6.1 (c) of the Distribution Agreement to the contrary,
Boule shall reimburse Heska for the cost and expense of returning non-conforming or defective Product as contemplated therein. 

        4.     Indemnification. Boule and Heska agree that the following phrase shall be deleted at the end of the second sentence of
Section 6.5 of the Distribution Agreement and shall have no further force and effect: "or any of its customers or from a defect for which Boule is not responsible". 

        5.     Consumable Sales after Termination. Unless Boule terminates the Distribution Agreement pursuant to Section 8 .2
thereof, Heska may purchase Consumables following termination of the Distribution Agreement as provided in Section 3.6 thereof, and for the avoidance of doubt, Heska's right to make such
purchases shall not obligate Heska to comply with the restrictions set forth in Section 2.3 thereof. However, if Heska sells non-Boule spare parts, consumables or reagents for the
Analyzer following termination of the Distribution Agreement (other than due to Boule's failure to timely fill Heska's orders for Consumables), then Heska's right to purchase Consumables shall expire. 

        6.     Sale of Refurbished ABC Systems and Scil Inventory. Notwithstanding any provision of the Distribution Agreement to the
contrary, including but not limited to Section 2.3 thereof, Boule agrees that Heska shall have the right, but not the obligation, to obtain and refurbish used ABC instruments
("Refurbished ABC Systems") and to sell such Refurbished ABC Systems within the Territory at any time after the date of this Amendment. In addition,
Heska shall have the right, but not the obligation, to sell its inventory of instruments and reagents purchased from Scil Animal Care Company, America, Inc., within the Territory, at any time
after the effective date of this Amendment. Heska shall provide monthly reports of sales of both new ABC Systems and Refurbished ABC Systems to Boule.

 

        This
letter will constitute a written agreement amending the Distribution Agreement as contemplated by Section 9.10 thereof. If there is a conflict between the terms of this
letter and the Distribution Agreement, this letter shall control. 

	

 	
 	

 	
 	

Very truly yours,
	

 	
 	

 	
 	

HESKA CORPORATION
	

 	
 	

 	
 	

By:	
 	

/s/  JASON NAPOLITANO      
 Jason Napolitano

Its: Chief Financial Officer

	
ACCEPTED AND AGREED:	
 	

 	
 	

 
	

BOULE MEDICAL AB	
 	

 	
 	

 
	

By:	
 	

/s/  ERNST WESTMAN      
 Ernst Westman

Its: President
	
 	

 	
 	

 

   Appendix A1  

        This Appendix forms an integrated part of the Supply and Distribution Agreement between BOULE and HESKA. 

Payment Terms  

        All prices are based on EX Works delivery terms, not insured. 

        Insurance
could be organized according to a request from the receiver. 

        All
additional costs are on the behalf of Heska, such as: 

	•
	L/C
cost

	•
	Legalization
costs

	•
	Courier 

        Minimum
order/invoicing amount: Euro 100 

Payment terms  

	•
	Boule
will invoice Heska twenty percent (20%) of the purchase price of instruments immediately upon acceptance of any purchase order. Heska shall wire the 20% payment
fourteen (14) days prior to shipment. Boule will invoice the balance of the purchase price upon shipment of Product from Boule's facility and Heska shall pay such invoice within
fifty-two (52) days from the date of invoice. This term shall be valid only as long as Heska complies with said payment term without delays, as judged by Boule. For payments
received in advance Heska will be granted a 2% discount.

	•
	Interest
rate of 2% per month will be charged for all invoices past due date. Interest invoices will be made, at least, twice a year.

	•
	Credit
limit is set to Euro five hundred thousand (500.000). 

 

[***]—Certain information on this page have been omitted and filed separately with the Securities and Exchange Commission.
Confidential treatment has been requested with respect to the omitted portions.

Appendix A2  

        This Appendix forms an integrated part of the Supply and Distribution Agreement between BOULE and HESKA. 

        Heska
agrees to make orders of the following Products in units divisible by two. Payment for fifty percent (50%) of the units in each shipment shall be made in Euros and fifty percent
(50%) in U.S.
dollars. The initial Euro prices are set forth below, subject to adjustment for actual changes in material and labor costs pursuant to the last paragraph of Section 4.1 of the Distribution
Agreement. The dollar prices shall be an amount equal to the then-current Euro price, multiplied by 1.18. 

	Description
 
	 	Price Net Euro

	INSTRUMENTS	 	 
	CA 629-20 Vet, 110/60	 	[***]
	CA 620-20 Vet with MPA, 110/60	 	[***]
	Micro Pipette Adapter MPA	 	[***]
	Micro Caps for MPA Pack size 10x1000	 	[***]
	Medonic micro lancet	 	[***]
	Printer DPU 414-2	 	[***]
	Printer paper to DPU 414-2, 5 rolls	 	[***]
	Barcode reader	 	[***]
	
REAGENTS	
 	

 
	Mediton vet, 10 Litre (for Medonic)	 	[***]
	Medityse vet, 5 Litre (for Medonic)	 	[***]
	ProClean Plus	 	[***]
	Hypochlorite	 	[***]

 

[***]—Certain information on this page have been omitted and filed separately with the Securities and Exchange Commission.
Confidential treatment has been requested with respect to the omitted portions.  

Appendix A3  

        Payment for one hundred percent (100%) of the units of the Products listed below shall be made in U.S. dollars. The initial U.S. dollar price for each of such
Products shall be the price set forth below, subject to adjustment for actual changes in raw material and labor costs pursuant to the last paragraph of Section 4.1 of the Distribution
Agreement. 

	Description
 
	 	Price Net

	REAGENTS	 	 
	Reagent Pack AB-Vet (for ABX)	 	[***]
	
CONTROLS & CALIBRATORS	
 	

 
	Boule—8 VET CON	 	 
	1x4.5 ml normal	 	[***]
	6x4.5 ml normal	 	[***]
	18x4.5 ml normal	 	[***]
	Boule—8 VET CAL	 	 
	1x3.0 ml	 	[***]

   [***]—Certain information on this page have been omitted and filed separately with the Securities and Exchange Commission.
Confidential treatment has been requested with respect to the omitted portions.  

Appendix A4  

        Payment for one hundred percent (100%) of the units of the Products listed below shall be made in Euros. The initial Euro price for each unit of such Products
shall be the price set forth below, subject to adjustment for actual changes in raw material and labor costs pursuant to the last paragraph of Section 4.1 of the Distribution Agreement. 

	 
	 	 
	 	 
	 	Spare Parts Price List

Medonic CA 530/620
	 	 
	 	 

	View
 
	 	 
	 	 
	 	Recommended

for stock
	 	Price

Euro

	 	Pos
	 	Art. No.
	 	Description

	530-04	 	5	 	5814064	 	Asp. pip. predil. blood/upps	 	Y	 	[***]
	530-04	 	4	 	5306007	 	Asp. Pipette Whole blood	 	Y	 	[***]
	530-02	 	92	 	9990389	 	Bearing	 	 	 	[***]
	530-02	 	83	 	9990676	 	Bi pin lampa	 	Y	 	[***]
	530-03	 	20	 	5308004	 	Cable assay blood detector	 	 	 	[***]
	530-02	 	84	 	5308013	 	Cable assy Hgb lamp	 	 	 	[***]
	530-02	 	70	 	5308008	 	Cable assy Hgb photocel	 	 	 	[***]
	530-02	 	21	 	5308014	 	Cable assy opto-switch	 	 	 	[***]
	530-02	 	43	 	5308011	 	Cable assy start/stop detector	 	 	 	[***]
	530-02	 	67	 	5308010	 	Cable assy syringe motor	 	 	 	[***]
	530-02	 	89	 	5308009	 	Cable assy transducer coax	 	 	 	[***]
	530-02	 	73	 	5306002	 	Cap. Holder complete	 	Y	 	[***]
	530-03	 	34	 	5814143	 	Casing complete	 	Y	 	[***]
	530-05	 	37	 	9990959	 	Check valve 1300-201.1	 	 	 	[***]
	530-04	 	17	 	5304022	 	Cleaning device	 	 	 	[***]
	530-02	 	78	 	5306004	 	Counting cup WBC complete	 	 	 	[***]
	530-02	 	71	 	5306003	 	Counting cup RBC complete	 	 	 	[***]
	530-04	 	55	 	9990434	 	Coupling T 20-6	 	Y	 	[***]
	530-04	 	37	 	9990435	 	Coupling DD-6	 	Y	 	[***]
	530-04	 	39	 	9990955	 	Coupling T 220-210-6	 	Y	 	[***]
	530-04	 	36	 	9990989	 	Coupling T220-6	 	Y	 	[***]
	530-04	 	38	 	9990437	 	Coupling Y220-6	 	Y	 	[***]
	530-03	 	16	 	5304097	 	Detector	 	 	 	[***]
	530-05	 	8	 	9990910	 	Fan for F-120	 	 	 	[***]
	530-02	 	75	 	9990598	 	Filter VG9 4mm Ø 8	 	 	 	[***]
	530-02	 	59	 	5306006	 	Gearbox complete	 	Y	 	[***]
	530-03	 	22	 	5306005	 	Gearbox complete	 	Y	 	[***]
	530-02	 	103	 	5304077	 	Glass cylinder	 	Y	 	[***]
	530-02	 	10	 	5304011	 	Guiding rod	 	 	 	[***]
	530-02	 	25	 	5304015	 	Guiding wheel	 	 	 	[***]
	 	 	 	 	9990900	 	Hal switch TLE 4905L	 	 	 	[***]
	530-2	 	105	 	5304075	 	Housing upper glass cylinder	 	 	 	[***]
	 	 	 	 	9990844	 	IC 82C55A	 	Y	 	[***]
	 	 	 	 	9990891	 	IC LM338K	 	 	 	[***]
	 	 	 	 	9990890	 	IC LT350AK	 	 	 	[***]
	 	 	 	 	9990847	 	IC PBL 3773	 	Y	 	[***]
	 	 	 	 	9990848	 	IC PBM 3960	 	Y	 	[***]
	530-02	 	45	 	4804014	 	Ind. Lower	 	Y	 	[***]
	530-04	 	23	 	5304002	 	Indicator housing	 	 	 	[***]

 

	620-01	 	2	 	6203018	 	Keyboard folio	 	 	 	[***]
	530-05	 	27	 	5306001	 	Level detector hemolyzer	 	 	 	[***]
	530-05	 	26	 	5306000	 	Level detector isoton	 	 	 	[***]
	530-04	 	9	 	9990395	 	Locking ring RS 4	 	Y	 	[***]
	530-01	 	38	 	9990479	 	Magnet lock	 	 	 	[***]
	530-02	 	7	 	9990402	 	Magnet valve one-way	 	Y	 	[***]
	530-02	 	8	 	9990403	 	Magnet valve two-way	 	Y	 	[***]
	530-05	 	42	 	9991128	 	Mains inlet	 	 	 	[***]
	530-02	 	47	 	5304026	 	Metering unit	 	Y	 	[***]
	 	 	 	 	2606001	 	Micocaps for MPA 260 10x100	 	Y	 	[***]
	530-04	 	20	 	5814036	 	Mixing cup/bl.bägare	 	 	 	[***]
	530-04	 	21	 	5303010	 	Mixing cup lid	 	Y	 	[***]
	530-05	 	11	 	9990405	 	Nipple	 	 	 	[***]
	530-02	 	16	 	5304020	 	Optical detector	 	 	 	[***]
	530-02	 	44	 	9990475	 	O-ring 5.30x 2.40 silikon	 	Y	 	[***]
	530-02	 	49	 	9990475	 	O-ring 5.30x 2.40 silikon	 	Y	 	[***]
	530-02	 	77	 	9990597	 	O-ring 7.10x 1.60	 	Y	 	[***]
	530-02	 	79	 	9990597	 	O-ring 7.10x 1.60	 	Y	 	[***]
	530-03	 	36	 	9991164	 	O-ring 22.00x 2.00 nitril	 	Y	 	[***]
	530-03	 	32	 	9990453	 	O-ring 5.10x1.60 nitril	 	Y	 	[***]
	530-02	 	104	 	9990468	 	O-ring 12.10x 1.60 epdm	 	Y	 	[***]
	530-02	 	74	 	9991085	 	O-ring 13.10x 1.6 nitril	 	Y	 	[***]
	530-02	 	69	 	9990382	 	O-ring 20.24x 2.62 viton	 	Y	 	[***]
	530-04	 	28	 	9990392	 	O-ring 22.10x 1.60 viton	 	Y	 	[***]
	530-04	 	13	 	9990887	 	O-ring 6.10x1.60 nitril	 	 	 	[***]
	530-06	 	3	 	5309021	 	PCB ampl 530 mounted complete	 	Y	 	[***]
	530-06	 	2	 	5309001	 	PCB CPU 530 mounted complete	 	Y	 	[***]
	620-01	 	4	 	6209001	 	PCB display CA620	 	Y	 	[***]
	530-06	 	8	 	5309011	 	PCB power mounted complete	 	Y	 	[***]
	530-06	 	27	 	9991161	 	Plastic cover	 	 	 	[***]
	530-05	 	7	 	9990422	 	Pump F120-28 24 AC	 	Y	 	[***]
	530-05	 	39	 	9980001	 	Repair kit for pump 9990422	 	Y	 	[***]
	530-03	 	9	 	5814120	 	Ring/främre styrh. v.	 	 	 	[***]
	530-03	 	6	 	5814119	 	Ring/mothåll fj.	 	 	 	[***]
	530-02	 	24	 	5814082	 	Ring/stoppring	 	 	 	[***]
	530-02	 	55	 	5304008	 	Rolled thread ball screw Shbo 12*4	 	 	 	[***]
	530-05	 	14	 	9990911	 	Rubber support, M4	 	 	 	[***]
	530-03	 	5	 	9990689	 	Sealing BA 8 18 5	 	Y	 	[***]
	530-02	 	124	 	5306009	 	Sealing piston complete	 	Y	 	[***]
	503-02	 	123	 	5306008	 	Sealing rod complete	 	Y	 	[***]
	530-01	 	62	 	5303042	 	Shield plate	 	 	 	[***]
	530-04	 	42	 	9990957	 	Spring 0,60*6,0*15	 	 	 	[***]
	530-03	 	7	 	9990439	 	Spring 1,00*12,0*20	 	 	 	[***]
	530-02	 	30	 	9990952	 	Spring 1,50*7,0*10	 	Y	 	[***]
	530-04	 	2	 	5304104	 	Start plate 1	 	 	 	[***]
	530-04	 	3	 	5304105	 	Start plate 2	 	 	 	[***]
	530-05	 	46	 	5304167	 	Tube ground con.	 	 	 	[***]
	530-04	 	54	 	9970031	 	Tubing pvc Ø 3.0/5.0	 	Y	 	[***]

 

	530-04	 	50	 	9970022	 	Tubing tef Ø 0.7/1.6	 	Y	 	[***]
	530-04	 	51	 	9970023	 	Tubing tef Ø 1.2/2.0	 	Y	 	[***]
	530-04	 	52	 	9970041	 	Tubing tyg Ø 0.8/2.4	 	Y	 	[***]
	530-04	 	53	 	9970042	 	Tubing tyg Ø 1.6/3.2	 	Y	 	[***]
	530-04	 	47	 	9970001	 	Tubing Ø sil 1,0/3,0	 	Y	 	[***]
	530-04	 	48	 	9970002	 	Tubing Ø sil 1,5/3,0	 	Y	 	[***]
	530-04	 	46	 	9970005	 	Tubing Ø sil 2,0/5,0	 	Y	 	[***]
	530-04	 	49	 	9970024	 	Tubing Ø tef, 1,6/3,2	 	Y	 	[***]
	530-03	 	35	 	5814142	 	Valve part f.	 	 	 	[***]
	530-03	 	10	 	5304048	 	Valve rear part	 	 	 	[***]

 

[***]—Certain information on this page have been omitted and filed separately with the Securities and Exchange Commission.
Confidential treatment has been requested with respect to the omitted portions.

Appendix A5  

        Heska agrees to make orders of the following Products in units divisible by two. Payment for fifty percent (50%) of the units of such Products in each shipment
shall be made in Euros and fifty percent (50%) in U.S. dollars. The Euro price shall initially be EUR [***] and shall be determined annually in accordance with the second
paragraph of Section 4.1 of the Distribution Agreement, subject to adjustment for actual changes in raw material and labor costs pursuant to the last paragraph of Section 4.1 of the
Distribution Agreement. The U.S. dollar price shall be fixed at USD [***], subject to adjustment for actual changes in raw material and labor costs pursuant to the last
paragraph of Section 4.1 of the Distribution Agreement. 

CA
620-16 Vet, 110/60

CA 620-16 Vet with MPA, 110/60 

   Appendix C  

Boule's
trademarks are:

Boule

Medonic

Swelab 

 

December 31,
2004 

Boule
Medical AB

P. O. Box 42056

SE-126 13 Stockholm, Sweden 

Attention:
Ernst Westman, President 

	Re:
	Supply
and Distribution Agreement ("Distribution Agreement") by and between Heska Corporation
("Heska") and Boule Medical AB ("Boule") dated June 17, 2003 

Dear
Mr. Westman: 

        This
letter confirms our agreement to amend our letter dated June 1, 2004 (the "First Amendment") to further interpret and
supplement the Distribution Agreement as follows (capitalized terms not otherwise defined herein have the meanings ascribed to them in the Distribution Agreement): 

        1.     Pricing and Payment. Appendix A1 attached to the First Amendment is hereby deleted and replaced with Appendix A1 attached
hereto. 

        This
letter will constitute a written agreement amending the Distribution Agreement as contemplated by Section 9.10 thereof. If there is a conflict between the terms of this
letter and the Distribution Agreement or the First Amendment, this letter shall control. 

	

 	
 	

 	
 	

Very truly yours,
	

 	
 	

 	
 	

HESKA CORPORATION
	

 	
 	

 	
 	

By:	
 	

/s/  JASON NAPOLITANO      
 Jason Napolitano

Its: Chief Financial Officer

	
ACCEPTED AND AGREED:	
 	

 	
 	

 
	

BOULE MEDICAL AB	
 	

 	
 	

 
	

By:	
 	

/s/  ERNST WESTMAN      
 Ernst Westman

Its: President
	
 	

 	
 	

 

 

Appendix A1  

        This Appendix forms an integrated part of the Supply and Distribution Agreement between BOULE and HESKA. 

Payment terms  

        All prices are based on EX Works delivery terms, not insured. 

        Insurance
could be organized according to a request from the receiver. 

        All
additional costs are on the behalf of Heska, such as: 

	•
	L/C
cost

	•
	Legalization
costs

	•
	Courier

        Minimum
order/invoicing amount: Euro 100 

Payment terms  

	•
	Boule
will invoice the purchase price upon shipment of Product from Boule's facility and Heska shall pay such invoice within forty-two (42) days from the
date of invoice. This term shall be valid only as long as Heska complies with said payment term without delays, as judged by Boule. For full payments received in advance of shipment Heska will be
granted a 2% discount.

	•
	Interest
rate of 2% per month will be charged for all invoices past due date. Interest invoices will be made, at least, twice a year.

	•
	Credit
limit is set to Euro five hundred thousand (500.000). 

QuickLinks

SUPPLY AND DISTRIBUTION AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00082-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00082-of-00352.parquet"}]]